The Directors hereby present their Sixty-third Annual Report on the
business and operations of the Company and the financial accounts for
the year ended 31st March, 2011.
FINANCIAL RESULTS
Rs. Crores
Gross Sales 2010-11 2009-10
Excise Duty 1127.63 933.48
Net Sales (80.91) (58.35)
Other Income 1046.72 875.13
34.36 28.82
1081.08 903.95
Profit/ (-) Loss before Interest, 204.05 173.17
Depreciation and Tax
Interest (3.32) (2.67)
Depreciation (17.16) (18.31)
Profit/ (-) Loss before Tax 183.57 152.19
Provision for Tax (50.70) (45.07)
For Prior Years 2.12 (1.82)
Deferred Tax (8.78) (4.26)
Profit/ (-) Loss after Tax 126.21 101.04
Balance of Profit brought forward from
previous year 157.19 183.21
283.40 284.25
Appropriations
Capital Redemption Reserve - (88.00)
Debenture Redemption Reserve (12.50) -
Preference Dividend paid on Redemption - (2.24)
Income Tax on Preference Dividend paid - (0.38)
Transfer from/ (to) General Reserve (12.62) (10.10)
Interim Dividend (17.50) (9.59)
Income Tax on Interim Dividend (2.91) (1.63)
Proposed Equity Dividend (21.39) (12.97)
Income tax on Equity Dividend (3.47) (2.15)
Balance Profit/(-) Loss carried forward
to Balance Sheet 213.01 157.19
DIVIDEND
The Board of Directors had declared an interim dividend of Rs. 9/- per
share (90%) on the Equity Shares of the Company, in October, 2010. The
Directors are pleased to recommend a final dividend of Rs. 11/- per
share (110%) on the Equity Shares. This will take the total dividend
for the year to Rs. 20/- per share (200%) on the post bonus equity
share capital of the Company (Previous year Rs. 18/- per share, i.e.
180%). If the final dividend, as recommended above, is declared by the
Members at the Annual General Meeting, the total outflow towards
dividend on Equity Shares for the year would be Rs. 45.27 Crores
(including dividend tax) (Previous Year Rs. 26.34 Crores).
COMPANY PERFORMANCE
The Companys profit before tax on a consolidated basis, increased to
Rs. 184.48 Crores during the year, as compared to Rs.152.71 Crores in
the previous year, a growth of 21% over the last year. The Company
earned a net profit of Rs. 126.04 Crores, as against a net profit of
Rs. 101.49 Crores in the previous year on a consolidated basis.
OPERATIONS
Crop Protection Chemicals
The Third Advance Estimates has projected an impressive increase in the
agricultural production driven by a reasonable growth of cereals,
improvement in oil seeds and cotton along with an excellent growth in
pulses.The total annual rainfall at the national level exceeded by 3%
compared to normal though the geographical spread and distribution was
uneven. The States of West Bengal, Bihar, Eastern UP, East MP and
Punjab reported more than 20% deficit in rainfall. This affected crop
acreages, pest/ disease incidence and had impact on yield in crops like
paddy, chilli, black gram, soybean and cotton.
The Domestic Formulation Business registered a healthy 20% growth
during the year over the previous year despite season aberration in
crops like paddy, pulses and chillis. The industry too recorded an
estimated growth of 12% - 15% over the previous year. Aggressive
planning and implementation of sales and promotion on paddy, cotton,
pulses, sugarcane and fruits & vegetables, taking into account
on-ground realities was a key to success. EAGLE (Expansion and
Aggressive Growth through Leadership and Excellence) roll out across
pan India has helped in opportunity identification, drawing actionable
insights and achievement of aggressive growth targets at crop pest and
molecule level for each territory. This resulted in significant
increase in volumes for our key products such as Applaud, Takumi,
Manik, Asataf, Ergon, Contaf Plus, Taqat and Tata Metri.
Our customer relationship building activities branded under the
umbrella of Rallis Kisan Kutumba (RKK) moved into the next orbit with
successful introduction of key initiatives like MoPu (grow More
Pulses), State partnership, Prerna and others. These initiatives, along
with customer centric promotional activities and product portfolio
current with the market needs, has helped farmers to a great extent in
protecting their crops effectively, improving quality and yield of
produce and ultimately in improving their standard of living. The RKK
today directly services over five lakh farmers.
The International Business Division registered an increase of 34% in
sales, as compared to 2009-10. The rise in sales was due to rising
demand for crop commodities and price improvement in wheat and cotton.
International Business comprised 23% of the total revenues of the
Company.
The Domestic Institutional Business continued with its sales of crop
protection and seed treatment chemicals and household pesticide
products to major customers during the year and was in line with our
expectations.
Seeds and Plant Growth Nutrients
During the year, your Company has acquired a 59.02% stake (on a fully
diluted basis) in Metahelix Life Sciences, a research-led Seeds
Company. This acquisition will firm up the Companys presence in the
entire Seeds Value Chain that comprises breeding, production and
marketing of seeds. With a strong seeds portfolio, the Company has been
able to broad base its offerings to the Indian farmer.
Your Company has established Ralligold, a Plant Growth Nutrient, across
the country during 2010-11, in crops like paddy, cotton, vegetables and
others. The focus during 2011-12 will be to create a formidable brand
out of Ralligold. Plant Growth Nutrient is a high growth area and your
Company is focusing on introduction of new product segments across
different crop segments and geographies.
RESEARCH & DEVELOPMENT
Research and Development efforts are focused on developing new
formulations for better efficacy, improved value for the farmer
including combination products and facile handling and delivery and
sustainable product solutions. Various new formulations have been
developed and are in the process of commercialization. A number of
registration dossiers have been submitted during the year for
supporting International Business.
Some compounds from the NMITLI (New Millennium Indian Technology
Leadership Initiative) project have shown bioactivity on basis of field
trial results. Based on these observations and results, a Provisional
Patent has been taken in India.
Process deveploment (Reverse Engineering) of molecules which are
off-patent but with relevant market potential in the areas of crop
protection was carried out. Process improvement projects were
undertaken for improving product quality and productivity of the
manufacturing processes. Enviornment, Health and Safety (EHS)
considerations were given special emphasis in the process development
work.
ADDITIONAL MANUFACTURING FACILITY
The Companys plan to set up additional manufacturing facilities has
progressed further during the year. Work has been completed
satisfactorily at the new facility at the PCPIR (Petroleum, Chemicals
and Petrochemical Investment Region), at Dahej in Gujarat and the
Company expects to commence commercial production from this facility in
Q1 of FY 2011-12. The Dahej plant will be a multi-purpose technical
manufacturing facility for a number of Crop Protection products. This
has enhanced the Companys ability to handle different type of
chemistries leading to an increase in the potential to attract contract
manufacturing from suitable alliance partners.
FINANCE
On 10th June, 2010, the Company allotted 64,82,296 fully paid-up Equity
Shares of Rs. 10/- each, as Bonus Shares to the Shareholders, in the
ratio of one Equity Share of Rs. 10/- each for every two Equity Shares
held in the Company.
During the year, the Company has raised Rs. 75 Crores by issue of 750,
9.05% Secured Redeemable Non Convertible Debentures 2010-11 Series-I,
of Rs. 10,00,000/- each, fully paid-up at par on Private Placement
basis, in accordance with the provisions of SEBI (Issue And Listing Of
Debt Securities) Regulations, 2008. The Debentures are listed on the
Wholesale Debt Market Segment of the Bombay Stock Exchange Ltd.
The Board of Directors of your Company has, subject to the requisite
approvals being obtained by the Company, approved the sub-division of
each of the Equity Shares of the face value of Rs. 10/- each fully
paid-up in the Equity Share Capital of the Company, into 10 Equity
Shares of the face value of Rs. 1/- each fully paid-up and
consequential amendments to the Capital Clauses in the Memorandum and
Articles of Association of the Company. Shareholders are requested to
refer to Item Nos.8 to 10 of the Notice of the Annual General Meeting
in this regard.
INDUSTRIAL RELATIONS
The overall relations with bargainable employees at all Units of the
Company were cordial and harmonious during the year 2010-11. The
overall manpower of the Company has increased from 846 to 918 during
the year. This increase is mainly due to manning of the new facilities
in Dahej. The management staff strength has increased from 660 to 738
and the non management staff strength has reduced from 186 to 180
during the year. The Company has amicably signed a long term settlement
with the recognized union at its Ankleshwar plant.
SUBSIDIARIES
The Ministry of Corporate Affairs has granted a general exemption to
companies, by General Circular No.2/2011 dated 8th February, 2011,
under Section 212 (8) of the Companies Act, 1956, from attaching
individual accounts of subsidiaries with its annual report.
Accordingly, the Board of Directors of the Company has, by resolution,
given consent for not attaching the Balance Sheet, Profit and Loss
Account and other documents of its subsidiaries in the Annual Report of
the Company for the financial year ended 31st March, 2011.
However, the Consolidated Financial Statements of the subsidiaries
(prepared in accordance with Accounting Standard 21 issued by the
Institute of Chartered Accountants of India), form part of the Annual
Report and are reflected in the Consolidated Accounts of the Company.
Further, the financial data of the subsidiaries have been furnished
under “Summary of Financial Information of Subsidiary Companies” and
forms part of this Annual Report. The annual accounts of the
subsidiaries and related detailed information will be kept at the
Registered Office of the Company, as also at the head offices of the
respective subsidiary companies and will be available to investors
seeking information at any time.
The consolidated financial results reflect the operations of the
following subsidiaries: Metahelix Life Sciences Ltd. (consolidated
with its wholly owned subsidiary Dhaanya Seeds Ltd.), Rallis
Australasia Pty Ltd. and Rallis Chemistry Exports Ltd.
DIRECTORS
Dr. S. Ramanathan will retire as Director of the Company at the
conclusion of the Annual General Meeting. The Directors wish to place
on record their appreciation of the valuable services rendered by Dr.
Ramanathan during his tenure as Director of your Company.
In accordance with Article 112(2) of the Articles of Association of the
Company, Mr. E. A. Kshirsagar, Mr. R. Gopalakrishnan, Mr. B. D.
Banerjee and Dr. K. P. Prabhakaran Nair retire and are eligible for
re-appointment.
DIRECTORS RESPONSIBILITY STATEMENT
Pursuant to Section 217(2AA) of the Companies Act, 1956, the Directors,
based on the representations received from the Operating Management,
confirm that:
(i) in the preparation of the annual accounts, the applicable
accounting standards have been followed and that there are no material
departures;
(ii) they have, in the selection of the accounting policies, consulted
the Statutory Auditors and have applied them consistently, and made
judgements and estimates that are reasonable and prudent, so as to give
a true and fair view of the state of affairs of the Company at the end
of the financial year and of the profit of the Company for that period;
(iii) they have taken proper and sufficient care, to the best of their
knowledge and ability, for the maintenance of adequate accounting
records in accordance with the provisions of the Companies Act, 1956,
for safeguarding the assets of the Company and for preventing and
detecting fraud and other irregularities;
(iv) they have prepared the annual accounts on a going concern basis.
CORPORATE GOVERNANCE AND INTERNAL AUDIT
Besides continuing the usage of expertise of a single firm of Internal
Auditors, the Internal Audit Department, under the direction of the
Head - Internal Audit, also undertook a substantial number of internal
audits by using internal resources, with a view to encompassing a
larger universe. The benefits through this twin-pronged approach
resulted in providing more assurance on compliance and sustenance in
internal controls. Besides, this approach has also helped in
establishing and evolving partnership with the various Function Owners.
The Enterprise Risk Management framework, as well as the CEO/ CFO
Certification framework as required under Clause 49 of the Listing
Agreements with the Stock Exchanges, for controls testing pertaining to
financial reporting, were well established.
A Report on Corporate Governance, as required under Clause 49 of the
Listing Agreement is annexed.
AUDITORS
At the Annual General Meeting, Members will be required to appoint
Auditors for the current year and fix their remuneration. M/s. Deloitte
Haskins & Sells, the existing Auditors have furnished a certificate
regarding their eligibility for re-appointment. The Directors recommend
that they be re-appointed as Auditors of the Company for the current
year.
COST AUDITORS
Pursuant to the directives of the Central Government under the
provisions of Section 233B of the Companies Act, 1956, M/s. N. I. Mehta
and Co., Cost Accountants have been appointed to conduct Cost Audits
relating to Insecticides (Technical Grade and Formulations) and
Fertilizers of the Company.
The due date for filling of the Cost Audit Reports for the financial
year 2009-10 was 30th September, 2010. The Company has filed the
Reports with the Ministry of Corporate Affairs on 27th September, 2010.
CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE
EARNINGS AND OUTGO
As required under Section 217(1)(e) of the Companies Act, 1956 read
with the Companies (Disclosure of Particulars in the Report of
Directors) Rules, 1988, the information relating to conservation of
energy, technology absorption and foreign exchange earnings and outgo
is annexed.
PARTICULARS OF EMPLOYEES
The information required under Section 217 (2A) of the Companies Act,
1956, read with the Companies (Particulars of Employees) Rules, 1975 as
amended, is provided in the Annexure forming part of the Report. In
terms of Section 219(1)(b)(iv) of the Act, the Report and Accounts are
being sent to the Shareholders excluding the aforesaid Annexure. Any
Shareholder interested in obtaining the same may write to the Company
Secretary at the Registered Office of the Company. None of the
employees listed in the said Annexure is related to any Director of the
Company.
ACKNOWLEDGEMENT
Your Directors wish to thank all the employees of the Company for their
dedicated service during the year. They would also like to place on
record their appreciation for the continued co-operation and support
received by the Company during the year from bankers, financial
institutions, business partners and other stakeholders.
On behalf of the Board of Directors
R. GOPALAKRISHNAN
Chairman
Mumbai,
29th April, 2011
|